Q3 2019 Investor Presentation slide image

Q3 2019 Investor Presentation

Working with others to raise sleep as a public priority sleepscore verily labs. Consumer tech joint venture with Dr. Oz and Pegasus Capital World's first non- contact sleep tracking mobile app Shows people how they sleep, and how they can improve their sleep Sleep research joint venture with Verily To study the health and financial impacts of untreated sleep apnea Based on research: Develop software solutions to help. identify, diagnose, treat and manage those with OSA ©2019 ResMed I Q3 2019 Investor Presentation | 15 ResMed
View entire presentation